Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Leigh Perreault

Concepts (326)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prediabetic State
23
2023
219
6.960
Why?
Diabetes Mellitus, Type 2
47
2023
2087
5.270
Why?
Hypoglycemic Agents
23
2023
1011
3.630
Why?
Insulin Resistance
29
2023
1072
3.510
Why?
Blood Glucose
31
2023
1827
2.850
Why?
Obesity
25
2023
2505
2.790
Why?
Weight Loss
13
2023
642
2.300
Why?
Cardiovascular Diseases
15
2020
1726
2.240
Why?
Muscle, Skeletal
19
2023
1468
2.150
Why?
Insulin
19
2023
2080
2.010
Why?
Diabetes Mellitus
11
2023
898
1.750
Why?
Sphingolipids
6
2023
57
1.690
Why?
Benzhydryl Compounds
3
2017
59
1.510
Why?
Glucose Intolerance
8
2020
137
1.490
Why?
Diabetic Angiopathies
3
2017
246
1.470
Why?
Triglycerides
10
2022
467
1.450
Why?
Overweight
7
2022
473
1.200
Why?
Diabetes Complications
2
2019
208
1.140
Why?
Diglycerides
5
2020
53
1.120
Why?
Glucosides
2
2017
36
1.110
Why?
Glucagon-Like Peptide 1
3
2023
100
1.050
Why?
Life Style
12
2020
428
1.040
Why?
Primary Health Care
6
2023
1502
0.980
Why?
Metformin
13
2023
274
0.960
Why?
Receptors, Gastrointestinal Hormone
1
2023
5
0.890
Why?
Glucose Tolerance Test
15
2021
343
0.870
Why?
Exercise
10
2017
1642
0.870
Why?
Goals
2
2021
145
0.830
Why?
Anti-Obesity Agents
1
2023
45
0.830
Why?
Humans
90
2023
114045
0.820
Why?
Adult
50
2023
30375
0.820
Why?
Health Equity
1
2023
53
0.800
Why?
Middle Aged
41
2023
26605
0.780
Why?
Liver
4
2014
1633
0.780
Why?
Nutrition Therapy
1
2022
30
0.770
Why?
Adipose Tissue
4
2023
545
0.720
Why?
Glucose Clamp Technique
9
2021
181
0.720
Why?
Hyperglycemia
4
2014
292
0.700
Why?
Primary Care Nursing
1
2019
3
0.680
Why?
Male
55
2023
55396
0.670
Why?
Female
60
2023
59324
0.660
Why?
Microvessels
1
2019
66
0.630
Why?
Insulin, Long-Acting
1
2019
53
0.620
Why?
Peripheral Vascular Diseases
1
2019
97
0.620
Why?
Obesity Management
1
2018
8
0.620
Why?
Body Mass Index
11
2023
1957
0.610
Why?
Glucagon-Like Peptide-1 Receptor
1
2019
73
0.610
Why?
Infant, Newborn, Diseases
1
2019
104
0.600
Why?
Awareness
1
2019
93
0.600
Why?
Fasting
4
2020
242
0.590
Why?
Risk Factors
19
2023
8614
0.580
Why?
Precision Medicine
1
2021
335
0.580
Why?
Weight Reduction Programs
2
2017
94
0.560
Why?
Policy
1
2018
137
0.560
Why?
Incretins
2
2021
15
0.540
Why?
Risk Management
1
2017
89
0.540
Why?
Rest
2
2017
103
0.530
Why?
Choristoma
1
2015
21
0.510
Why?
Sleep Deprivation
5
2021
167
0.500
Why?
Insulin-Secreting Cells
2
2010
317
0.500
Why?
Weight Gain
4
2019
453
0.460
Why?
Lipid Metabolism
4
2021
441
0.450
Why?
Randomized Controlled Trials as Topic
4
2022
1204
0.440
Why?
Glucose
4
2023
899
0.430
Why?
Clinical Trials as Topic
1
2017
926
0.420
Why?
Phenols
1
2013
82
0.410
Why?
Glucagon-Like Peptides
2
2022
22
0.380
Why?
Physical Endurance
5
2020
232
0.380
Why?
Aged
17
2023
18969
0.370
Why?
Fenofibrate
1
2011
24
0.360
Why?
Hospitalization
1
2019
1762
0.360
Why?
Hypolipidemic Agents
1
2011
86
0.350
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2010
43
0.340
Why?
Palmitates
1
2009
16
0.340
Why?
Pyrazines
1
2010
71
0.340
Why?
Biomarkers
8
2023
3397
0.330
Why?
Energy Metabolism
4
2021
727
0.330
Why?
Sleep
4
2021
631
0.330
Why?
Triazoles
1
2010
125
0.320
Why?
Athletes
6
2020
328
0.320
Why?
Cross-Sectional Studies
7
2023
4402
0.310
Why?
Sex Characteristics
3
2021
636
0.290
Why?
Ceramides
3
2022
91
0.290
Why?
Diabetic Nephropathies
2
2020
234
0.290
Why?
Risk Reduction Behavior
3
2023
200
0.290
Why?
Sodium-Glucose Transporter 2
2
2017
17
0.280
Why?
Sex Factors
5
2018
1706
0.280
Why?
Absenteeism
2
2018
40
0.270
Why?
Markov Chains
2
2018
114
0.270
Why?
Pilot Projects
2
2021
1360
0.260
Why?
Health Services
2
2018
103
0.260
Why?
Renal Insufficiency, Chronic
2
2022
486
0.260
Why?
Adiponectin
3
2018
213
0.260
Why?
Follow-Up Studies
6
2021
4392
0.250
Why?
Circadian Rhythm
3
2019
356
0.250
Why?
Lipids
3
2015
564
0.250
Why?
Remission Induction
3
2019
233
0.250
Why?
Young Adult
11
2019
10444
0.240
Why?
Double-Blind Method
4
2022
1656
0.240
Why?
Dietary Fats
3
2020
287
0.220
Why?
Lipogenesis
2
2017
56
0.220
Why?
Lipoprotein Lipase
1
2004
54
0.220
Why?
Consensus
3
2020
532
0.210
Why?
Socioeconomic Factors
2
2018
1080
0.210
Why?
Computer Simulation
2
2018
873
0.210
Why?
Physical Exertion
1
2004
209
0.210
Why?
Healthy Lifestyle
1
2023
30
0.210
Why?
Energy Intake
4
2021
427
0.200
Why?
Diet, Reducing
3
2017
76
0.200
Why?
Prevalence
2
2019
2247
0.200
Why?
Biopsy
3
2018
1024
0.200
Why?
Combined Modality Therapy
4
2019
1117
0.200
Why?
Sarcolemma
2
2020
29
0.190
Why?
Cluster Analysis
1
2023
452
0.190
Why?
Endpoint Determination
2
2019
68
0.190
Why?
Muscle Fibers, Skeletal
2
2023
185
0.190
Why?
Nephrology
1
2022
48
0.190
Why?
Cytosol
2
2020
201
0.190
Why?
Glucose Transporter Type 4
1
2021
36
0.180
Why?
Ambulatory Care Facilities
1
2023
212
0.180
Why?
Carnitine
1
2021
62
0.180
Why?
Oxidation-Reduction
3
2021
917
0.170
Why?
Risk Adjustment
1
2020
76
0.170
Why?
Endocrinologists
1
2020
12
0.170
Why?
New Zealand
1
2019
40
0.170
Why?
Pragmatic Clinical Trials as Topic
1
2019
47
0.170
Why?
Endoplasmic Reticulum
2
2020
234
0.170
Why?
Cytosine
1
2019
43
0.170
Why?
Adolescent
8
2023
17800
0.160
Why?
Fatty Liver
1
2021
209
0.160
Why?
United States
9
2023
12137
0.160
Why?
Exercise Test
3
2015
547
0.160
Why?
Liraglutide
1
2019
27
0.160
Why?
Fatty Acids, Nonesterified
2
2019
150
0.160
Why?
Retinal Diseases
1
2019
76
0.160
Why?
Models, Econometric
1
2018
34
0.150
Why?
Colorado
3
2023
4090
0.150
Why?
Referral and Consultation
1
2023
632
0.150
Why?
Postprandial Period
1
2019
87
0.150
Why?
Quinolizines
1
1997
4
0.150
Why?
Drug Combinations
1
2019
286
0.150
Why?
Dose-Response Relationship, Drug
2
2019
1836
0.150
Why?
Antiemetics
1
1997
32
0.140
Why?
Severity of Illness Index
2
2018
2537
0.140
Why?
Tissue Plasminogen Activator
2
2018
204
0.140
Why?
Nausea
1
1997
99
0.140
Why?
Cholesterol, HDL
2
2015
184
0.140
Why?
Health Resources
1
2018
120
0.140
Why?
Vomiting
1
1997
122
0.140
Why?
Hysterectomy
1
1997
105
0.140
Why?
Surgical Wound Infection
1
2019
246
0.140
Why?
Odds Ratio
1
2019
951
0.130
Why?
Treatment Outcome
6
2021
9049
0.130
Why?
Patient-Centered Care
1
2021
470
0.130
Why?
Patient Participation
1
2019
348
0.130
Why?
Body Weight
3
2015
868
0.130
Why?
Research Design
2
2019
919
0.130
Why?
Delivery of Health Care
1
2023
828
0.130
Why?
Exercise Therapy
2
2017
351
0.130
Why?
Phosphatidylethanolamines
1
2016
66
0.130
Why?
Eating
2
2021
344
0.130
Why?
Kidney Diseases
1
2019
349
0.130
Why?
Blotting, Western
2
2016
1143
0.130
Why?
Cost-Benefit Analysis
1
2018
544
0.130
Why?
Indoles
1
1997
300
0.120
Why?
Phosphatidylcholines
1
2016
132
0.120
Why?
Qualitative Research
1
2019
919
0.120
Why?
Patient Compliance
1
2019
524
0.120
Why?
Costs and Cost Analysis
1
2015
196
0.120
Why?
Hypoglycemia
1
2019
386
0.120
Why?
Sleep Apnea Syndromes
1
2015
74
0.120
Why?
Income
1
2015
167
0.120
Why?
Logistic Models
1
2019
1829
0.120
Why?
Pneumonia
1
2019
563
0.110
Why?
Health Personnel
1
2019
569
0.110
Why?
Somatostatin
1
2014
52
0.110
Why?
Employment
1
2015
137
0.110
Why?
Recovery of Function
2
2015
573
0.110
Why?
Smoking
2
2012
1382
0.110
Why?
Fructose
1
2014
100
0.110
Why?
Cost of Illness
1
2015
254
0.110
Why?
Multicenter Studies as Topic
1
2014
249
0.110
Why?
Aged, 80 and over
3
2019
6306
0.110
Why?
Metabolic Diseases
1
2014
98
0.110
Why?
Oxygen Consumption
4
2016
587
0.110
Why?
C-Reactive Protein
1
2015
362
0.100
Why?
Fatty Acids, Monounsaturated
1
2012
47
0.100
Why?
Prospective Studies
3
2019
6195
0.100
Why?
Mitochondria
1
2018
744
0.100
Why?
Homeostasis
1
2016
570
0.100
Why?
Depressive Disorder, Major
1
2015
301
0.100
Why?
Models, Theoretical
1
2016
513
0.100
Why?
Practice Guidelines as Topic
1
2019
1381
0.100
Why?
Adult Children
1
2011
21
0.100
Why?
Age Factors
1
2018
2885
0.090
Why?
Placebos
2
2009
197
0.090
Why?
Diabetes, Gestational
1
2015
281
0.090
Why?
Adipocytes
1
2012
188
0.090
Why?
Metabolomics
1
2015
511
0.090
Why?
Health Behavior
2
2023
701
0.090
Why?
Quality of Life
3
2019
2343
0.090
Why?
Comorbidity
1
2015
1447
0.090
Why?
Health Knowledge, Attitudes, Practice
1
2019
1168
0.090
Why?
Sitagliptin Phosphate
1
2010
30
0.090
Why?
Longevity
1
2011
136
0.090
Why?
Family Health
1
2011
193
0.090
Why?
Mitochondria, Muscle
2
2021
92
0.080
Why?
C-Peptide
1
2010
138
0.080
Why?
Tandem Mass Spectrometry
1
2012
410
0.080
Why?
Delphi Technique
2
2019
157
0.080
Why?
Menopause
1
2011
271
0.080
Why?
Leisure Activities
1
2008
25
0.070
Why?
Blood Pressure
1
2014
1531
0.070
Why?
Body Composition
1
2011
590
0.070
Why?
Postoperative Complications
1
1997
2122
0.070
Why?
Mass Screening
1
2013
979
0.070
Why?
Risk Assessment
3
2015
2958
0.070
Why?
Predictive Value of Tests
1
2012
1791
0.070
Why?
Cohort Studies
4
2021
4883
0.070
Why?
Diabetes Mellitus, Type 1
2
2012
3254
0.070
Why?
Fibrinogen
2
2018
143
0.070
Why?
Aging
1
2015
1611
0.060
Why?
Multivariate Analysis
1
2009
1422
0.060
Why?
Regression Analysis
2
2019
945
0.060
Why?
Retrospective Studies
2
2019
12521
0.060
Why?
Incidence
3
2019
2314
0.060
Why?
Gene Expression Profiling
2
2023
1518
0.060
Why?
Prognosis
2
2023
3315
0.060
Why?
Depression
1
2012
1133
0.060
Why?
Health Expenditures
1
1986
172
0.060
Why?
Metabolic Clearance Rate
1
2004
102
0.060
Why?
Mice, Inbred C57BL
1
2013
4680
0.060
Why?
Parents
1
2011
1181
0.050
Why?
Alcohol Drinking
1
2009
650
0.050
Why?
Hormones
1
2004
132
0.050
Why?
Menstrual Cycle
1
2003
108
0.050
Why?
Eligibility Determination
1
2023
59
0.050
Why?
Wakefulness
2
2015
128
0.050
Why?
Lactic Acid
1
2003
272
0.050
Why?
Proportional Hazards Models
2
2017
1078
0.050
Why?
Disease Progression
2
2019
2371
0.050
Why?
Citric Acid Cycle
1
2021
43
0.050
Why?
Subcellular Fractions
1
2021
77
0.050
Why?
Injections, Subcutaneous
1
2021
134
0.050
Why?
Sex Hormone-Binding Globulin
1
2020
48
0.040
Why?
Motor Activity
2
2015
635
0.040
Why?
Kinetics
1
2004
1547
0.040
Why?
Protective Agents
1
2020
37
0.040
Why?
Education
1
2020
93
0.040
Why?
Pregnancy
2
2015
5499
0.040
Why?
Proprotein Convertase 9
1
2020
61
0.040
Why?
Stearoyl-CoA Desaturase
2
2010
53
0.040
Why?
Time Factors
3
2019
6077
0.040
Why?
Analysis of Variance
2
2013
1218
0.040
Why?
Poisson Distribution
1
2019
71
0.040
Why?
Stakeholder Participation
1
2019
72
0.040
Why?
E-Selectin
1
2018
52
0.040
Why?
Consensus Development Conferences as Topic
1
2018
28
0.040
Why?
Subcutaneous Fat
1
2019
70
0.040
Why?
Chemokine CCL2
1
2018
104
0.040
Why?
Probability
1
2019
286
0.040
Why?
Primary Cell Culture
1
2019
148
0.040
Why?
Intra-Abdominal Fat
1
2019
77
0.040
Why?
Intercellular Adhesion Molecule-1
1
2018
147
0.040
Why?
Cell Nucleus
1
2020
552
0.040
Why?
Research
1
2020
389
0.040
Why?
Diet
3
2012
1080
0.040
Why?
Leptin
1
2018
210
0.040
Why?
Case-Control Studies
2
2017
3003
0.040
Why?
Metabolome
1
2019
274
0.030
Why?
Adaptation, Physiological
2
2010
484
0.030
Why?
Sequence Analysis, RNA
1
2019
388
0.030
Why?
Biological Transport
1
2017
374
0.030
Why?
Longitudinal Studies
2
2013
2384
0.030
Why?
Fatty Acids, Unsaturated
1
2016
84
0.030
Why?
Diet, Fat-Restricted
1
2015
73
0.030
Why?
Blood Glucose Self-Monitoring
1
2020
505
0.030
Why?
Kidney
1
2022
1182
0.030
Why?
Melatonin
1
2015
106
0.030
Why?
Interleukin-6
1
2018
673
0.030
Why?
Fatty Acids
1
2016
380
0.030
Why?
Calorimetry
1
2013
60
0.030
Why?
Algorithms
1
2020
1469
0.030
Why?
Insulin Receptor Substrate Proteins
1
2012
56
0.030
Why?
Risk
1
2015
810
0.030
Why?
Sleep Wake Disorders
1
2015
232
0.030
Why?
Glycerol
1
2012
84
0.030
Why?
RNA, Messenger
2
2010
2550
0.030
Why?
Animals
1
2013
31565
0.020
Why?
Surveys and Questionnaires
1
2022
4595
0.020
Why?
Antidepressive Agents
1
2012
195
0.020
Why?
Genetic Variation
1
2015
868
0.020
Why?
Calorimetry, Indirect
1
2010
69
0.020
Why?
Palmitic Acid
1
2010
37
0.020
Why?
Polysomnography
1
2010
136
0.020
Why?
Nicotine
1
2012
265
0.020
Why?
Gene Expression Regulation
1
2019
2322
0.020
Why?
TOR Serine-Threonine Kinases
1
2012
359
0.020
Why?
Retinoid X Receptor gamma
1
2009
4
0.020
Why?
PPAR alpha
1
2009
52
0.020
Why?
Women's Health
1
2011
270
0.020
Why?
Bicycling
1
2010
86
0.020
Why?
Coronary Disease
1
2011
348
0.020
Why?
Phospholipids
1
2010
194
0.020
Why?
Phosphorylation
1
2012
1558
0.020
Why?
Reference Values
1
2009
739
0.020
Why?
Genetic Predisposition to Disease
1
2015
2090
0.020
Why?
Adiposity
1
2012
458
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
924
0.020
Why?
Patient Education as Topic
1
2011
666
0.020
Why?
Genotype
1
2011
1757
0.020
Why?
Infant Care
1
1986
42
0.020
Why?
Infertility
1
1986
45
0.020
Why?
Health Promotion
1
2011
675
0.020
Why?
Delivery, Obstetric
1
1986
118
0.010
Why?
Maternal Health Services
1
1986
79
0.010
Why?
Abortion, Induced
1
1986
71
0.010
Why?
Contraception
1
1986
117
0.010
Why?
Follicular Phase
1
2003
36
0.010
Why?
Anaerobic Threshold
1
2003
22
0.010
Why?
Spectrophotometry, Ultraviolet
1
2003
73
0.010
Why?
Luteal Phase
1
2003
41
0.010
Why?
Polymorphism, Single Nucleotide
1
2011
1880
0.010
Why?
Catecholamines
1
2003
94
0.010
Why?
Heart Rate
1
2003
710
0.010
Why?
Infant, Newborn
1
1986
5038
0.010
Why?
Perreault's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)